• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲社区药房实践中药物相关问题的识别、分类与记录:一项范围综述

Identification, classification, and documentation of drug related problems in community pharmacy practice in Europe: a scoping review.

作者信息

Hochhold Danielle, Nørgaard Lotte Stig, Stewart Derek, Weidmann Anita Elaine

机构信息

Department of Clinical Pharmacy, Leopold-Franzens Universität, Innsbruck, Austria.

Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.

出版信息

Int J Clin Pharm. 2025 Apr;47(2):247-269. doi: 10.1007/s11096-024-01834-7. Epub 2025 Jan 8.

DOI:10.1007/s11096-024-01834-7
PMID:39775382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11920317/
Abstract

BACKGROUND

Drug-related problems (DRPs) are significant issues in healthcare contributing to adverse health outcomes and increased healthcare costs. While community pharmacists play a pivotal role in identifying, classifying, and documenting DRPs, there is a need to map approaches undertaken.

AIM

The aim of this scoping review was to examine the approaches to identifying, classifying, and documenting DRPs in community pharmacies in Europe, and their associated barriers and facilitators.

METHOD

The scoping review was conducted according to the Joanna Briggs Institute guidelines and reported according to the PRISMA-ScR guidelines. The search was conducted across 11 databases from inception until March 2023. Studies of all designs reporting DRPs in European community pharmacies were included. Titles, abstracts, and full texts were screened independently by two researchers, followed by data extraction and synthesis.

RESULTS

The search yielded 67 relevant studies. Forty-eight studies described approaches to DRP identification as predominantly relying on professional knowledge and computer software. The classification methods, described in 41 studies, varied with reports of predefined systems and computer-generated classifications. Documentation approaches were described in 53 studies and were primarily computer-based. Facilitators included electronic support systems, pharmacist experience, while barriers encompassed the complexity of classification as well as variations in training, IT solutions, operational structures, and implementation.

CONCLUSION

There is a lack of a standardized approach to identifying, classifying, and documenting DRPs in European community pharmacies. A framework for pharmacist education and a time-saving approach to documenting DRPs consistently could serve to overcome the barriers to their identification and documentation. Furthermore, the implementation of a standardised approach to classifying DRPs could facilitate comparison of the management of DRPs across Europe.

摘要

背景

药物相关问题(DRPs)是医疗保健中的重大问题,会导致不良健康后果并增加医疗成本。虽然社区药剂师在识别、分类和记录药物相关问题方面发挥着关键作用,但有必要梳理所采用的方法。

目的

本范围综述的目的是研究欧洲社区药房中识别、分类和记录药物相关问题的方法,以及与之相关的障碍和促进因素。

方法

范围综述按照乔安娜·布里格斯研究所的指南进行,并根据PRISMA-ScR指南报告。检索从数据库建立至2023年3月期间的11个数据库。纳入所有报告欧洲社区药房药物相关问题的各类研究。由两名研究人员独立筛选标题、摘要和全文,随后进行数据提取和综合分析。

结果

检索得出67项相关研究。48项研究描述了药物相关问题识别方法主要依赖专业知识和计算机软件。41项研究中描述的分类方法各不相同,有预定义系统和计算机生成分类的报告。53项研究描述了记录方法,主要基于计算机。促进因素包括电子支持系统、药剂师经验,而障碍包括分类的复杂性以及培训、信息技术解决方案、运营结构和实施方面的差异。

结论

欧洲社区药房在识别、分类和记录药物相关问题方面缺乏标准化方法。药剂师教育框架和一种始终如一的节省时间的药物相关问题记录方法有助于克服识别和记录方面的障碍。此外,实施标准化的药物相关问题分类方法可以促进欧洲各地药物相关问题管理的比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4283/11920317/28f70f4dc431/11096_2024_1834_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4283/11920317/28f70f4dc431/11096_2024_1834_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4283/11920317/28f70f4dc431/11096_2024_1834_Fig1_HTML.jpg

相似文献

1
Identification, classification, and documentation of drug related problems in community pharmacy practice in Europe: a scoping review.欧洲社区药房实践中药物相关问题的识别、分类与记录:一项范围综述
Int J Clin Pharm. 2025 Apr;47(2):247-269. doi: 10.1007/s11096-024-01834-7. Epub 2025 Jan 8.
2
Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial.澳大利亚社区药店中发现的与药物相关的问题:PROMISe 试验。
Ann Pharmacother. 2011 Sep;45(9):1067-76. doi: 10.1345/aph.1Q138. Epub 2011 Aug 30.
3
DOCUMENT: a system for classifying drug-related problems in community pharmacy.文档:一个用于社区药房药物相关问题分类的系统。
Int J Clin Pharm. 2012 Feb;34(1):43-52. doi: 10.1007/s11096-011-9583-1. Epub 2011 Nov 19.
4
Survey of drug-related problems identified by community pharmacies.社区药房发现的药物相关问题调查。
Ann Pharmacother. 2007 Nov;41(11):1825-32. doi: 10.1345/aph.1K207. Epub 2007 Oct 9.
5
Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.药剂师在比利时社区药房处理抗血栓药物处方问题中的作用。
Int J Clin Pharm. 2015 Aug;37(4):656-68. doi: 10.1007/s11096-015-0106-3. Epub 2015 Mar 31.
6
Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study.匈牙利社区药房用药评估及药物相关问题的定性和定量研究:一项试点研究。
BMC Health Serv Res. 2019 May 3;19(1):282. doi: 10.1186/s12913-019-4114-1.
7
Practical evaluation of the drug-related problem management process in Swiss community pharmacies.瑞士社区药房药物相关问题管理流程的实践评估
Pharm World Sci. 2008 Dec;30(6):777-86. doi: 10.1007/s11096-008-9217-4. Epub 2008 Apr 6.
8
Community pharmacists' routine provision of drug-related problem-reduction services.社区药剂师提供的常规药物相关问题减少服务。
PLoS One. 2022 May 4;17(5):e0267379. doi: 10.1371/journal.pone.0267379. eCollection 2022.
9
Development of an aggregated system for classifying causes of drug-related problems.用于对药物相关问题的原因进行分类的综合系统的开发。
Ann Pharmacother. 2015 Apr;49(4):405-18. doi: 10.1177/1060028014568008. Epub 2015 Jan 22.
10
Pharmaceutical care in community pharmacies: practice and research in Sweden.社区药房的药学服务:瑞典的实践与研究
Ann Pharmacother. 2006 Jun;40(6):1162-9. doi: 10.1345/aph.1G680. Epub 2006 May 30.

引用本文的文献

1
The second victim experience and support tool: a cross-cultural adaptation, validation and psychometric evaluation of the Serbian version for pharmacy professionals (SR-SVEST-R).第二个受害者体验与支持工具:针对药剂师专业人员的塞尔维亚语版本(SR-SVEST-R)的跨文化改编、验证及心理测量学评估
Int J Clin Pharm. 2025 Jun;47(3):803-814. doi: 10.1007/s11096-025-01875-6. Epub 2025 Feb 13.

本文引用的文献

1
Using national data to describe characteristics and determine acceptance factors of pharmacists' interventions: a six-year longitudinal study.利用国家数据描述药剂师干预措施的特征并确定其接受因素:一项为期六年的纵向研究。
Int J Clin Pharm. 2023 Apr;45(2):430-441. doi: 10.1007/s11096-022-01526-0. Epub 2022 Dec 24.
2
Development and retrospective evaluation of a clinical decision support system for the efficient detection of drug-related problems by clinical pharmacists.开发并回顾性评估一个临床药师高效检测药物相关问题的临床决策支持系统。
Int J Clin Pharm. 2023 Apr;45(2):406-413. doi: 10.1007/s11096-022-01505-5. Epub 2022 Dec 14.
3
Drug-related emergency department visits in older patients: an applicability and reliability study of an existing assessment tool.
老年患者药物相关急诊科就诊:现有评估工具的适用性和可靠性研究。
Int J Clin Pharm. 2022 Aug;44(4):1078-1082. doi: 10.1007/s11096-022-01456-x. Epub 2022 Jul 15.
4
Community pharmacists' routine provision of drug-related problem-reduction services.社区药剂师提供的常规药物相关问题减少服务。
PLoS One. 2022 May 4;17(5):e0267379. doi: 10.1371/journal.pone.0267379. eCollection 2022.
5
Development of a model of medication review for use in clinical practice: Bristol medication review model.用于临床实践的药物评估模型的开发:布里斯托尔药物评估模型
BMC Med. 2021 Nov 10;19(1):262. doi: 10.1186/s12916-021-02136-9.
6
Drug-Related Problems of Patients in Primary Health Care Institutions: A Systematic Review.基层医疗卫生机构患者的药物相关问题:一项系统综述
Front Pharmacol. 2021 Aug 17;12:698907. doi: 10.3389/fphar.2021.698907. eCollection 2021.
7
Analysis of interaction risks of patients with polypharmacy and the pharmacist interventions performed to solve them-A multicenter descriptive study according to medication reviews in Hungarian community pharmacies.多药治疗患者的相互作用风险分析及药师干预措施以解决这些问题-一项基于匈牙利社区药房药物重整的多中心描述性研究。
PLoS One. 2021 Jun 22;16(6):e0253645. doi: 10.1371/journal.pone.0253645. eCollection 2021.
8
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
9
Medication Risk Management in Routine Dispensing in Community Pharmacies.社区药店常规配药中的药物风险管理。
Int J Environ Res Public Health. 2020 Nov 5;17(21):8186. doi: 10.3390/ijerph17218186.
10
Preventable medication harm across health care settings: a systematic review and meta-analysis.在医疗保健环境中可预防的药物伤害:系统评价和荟萃分析。
BMC Med. 2020 Nov 6;18(1):313. doi: 10.1186/s12916-020-01774-9.